An Unusual Association Between Metformin and Nightmares: A Case Report.

Autor: Voloshyna D; School of Medicine, University of Michigan, Ann Arbor, USA., Sandhu QI; Medicine, Ghazi Khan Medical College, Dera Ghazi Khan, PAK., Khan S; Internal Medicine, Sir Syed College of Medical Sciences for Girls, Clifton, PAK., Bseiso A; College of Medicine, Al-Quds University, Jerusalem, PSE., Mengar J; Medicine and Surgery, Government Medical College and New Civil Hospital, Surat, IND., Nayudu N; Internal Medicine, Zhengzhou University, Zhengzhou, CHN., Kumar R; Medicine and Surgery, Jinnah Sindh Medical University, Karachi, PAK., Khemani D; Medicine and Surgery, Jinnah Sindh Medical University, Karachi, PAK., Usama M; Neurology, Sheikh Zayed Medical College, Rahim Yar Khan, Rahim Yar Khan, PAK.
Jazyk: angličtina
Zdroj: Cureus [Cureus] 2022 Sep 09; Vol. 14 (9), pp. e28974. Date of Electronic Publication: 2022 Sep 09 (Print Publication: 2022).
DOI: 10.7759/cureus.28974
Abstrakt: Metformin remains the oral drug of choice for patients with type 2 diabetes mellitus (T2DM). It is an ideal anti-diabetic drug for maintaining good glycemic control in diabetics. However, the side effect profile of metformin varies from minor or no effects to substantial impact on the GI tract. In addition, metformin is rarely known for its association with nightmares. Here we present the case of a newly diagnosed 40-year-old diabetic who developed recurrent nightmares within a week of starting metformin treatment. The patient had no previous history of psychiatric or sleep disorders. However, it was the first time he had experienced such recurrent nightmares, especially after the start of 500 mg metformin thrice a day. Based on the Naranjo Adverse Drug Reaction (ADR) Probability Scale, and sudden onset and disappearance of nightmares after metformin initiation and discontinuation made metformin the primary cause of his nightmares.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2022, Voloshyna et al.)
Databáze: MEDLINE